Investor AB
Investor AB is the company that holds the Wallenberg family's stakes. Part of it is listed: Atlas Copco, ABB, AstraZeneca, Epiroc and Saab among them. Part of it is businesses it owns outright, and part is the stake in EQT. It is not Berkshire Hathaway. Atlas Copco already has its own report: here it is a stake, not the compressor.
Some stakes are controlling and some are not. This report does not state the percentage and does not certify a century of beating the market. The group's value is that portfolio, not a factory. If the listed company falls, the holding falls with it.
The dividend comes from the dividends it collects and from what it sells. It has to fit. It is not a toll on the companies in the portfolio.
"The advantage is the portfolio already assembled and the family governance that does not change thesis every year. The shareholder in the listed company can sell. It is not a closed door to northern businesses. The moat narrows if the stake is diluted, or if the discount to portfolio value stays and the dividend does not offset it."
Loading the Vaultflake…
—
Health is the holding company's debt, not AstraZeneca's or Atlas's. Quality is the result of the holdings, which is not a factory margin. Growth follows what those companies earn and what gets bought. Valuation is read against the value of the portfolio, not against a P/E of a good year. Shareholder return is the dividend, checked against the cash that comes in from the holdings.
Investor's P/E is not Atlas Copco's P/E. What matters is the portfolio value against the holding's price, and the debt in between. Do not use one holding's multiple as if it were the group. A dash if the INVE-B.ST cache is cold.
Not advice on Investor. Vaultflake does not split listed stakes, subsidiaries and EQT and does not treat a century of returns as won. Read the filings. A past dividend is not a right. The table is a snapshot, not a target price.
The advantage is the portfolio already assembled and the family governance that does not change thesis every year. The shareholder in the listed company can sell. It is not a closed door to northern businesses. The moat narrows if the stake is diluted, or if the discount to portfolio value stays and the dividend does not offset it.
Health is the holding company's debt, not AstraZeneca's or Atlas's. Quality is the result of the holdings, which is not a factory margin. Growth follows what those companies earn and what gets bought. Valuation is read against the value of the portfolio, not against a P/E of a good year. Shareholder return is the dividend, checked against the cash that comes in from the holdings.
Investor's P/E is not Atlas Copco's P/E. What matters is the portfolio value against the holding's price, and the debt in between. Do not use one holding's multiple as if it were the group. A dash if the INVE-B.ST cache is cold.
Not advice on Investor. Vaultflake does not split listed stakes, subsidiaries and EQT and does not treat a century of returns as won. Read the filings. A past dividend is not a right. The table is a snapshot, not a target price.
Financials · Diversified Banking
Financials · Diversified Banking
Financials · Holding Company
Financials · Asset Management
Financials · Wealth and Investment Banking
Financials · Investment Banking
A free account opens the interactive chart. The Vault assistant is Premium.